Binance Labs, the venture capital arm of the world’s leading cryptocurrency exchange, Binance, has announced its first investment in the Decentralized Science (DeSci) sector with BIO Protocol. This strategic move signifies Binance Labs’ commitment to supporting groundbreaking advancements in technology that have real-world impact.
🚨 New details on #DeSci Day just dropped–happening on 13 Nov as part of our BUIDLer House Bangkok event lineup, the session will bring together pioneering minds in biotech, DeSci, and Web3, for an afternoon of insightful talks, project pitches, and networking with top innovators… pic.twitter.com/vn8eXA4YJY
— Binance Labs Fund (@BinanceLabs) November 8, 2024
BIO Protocol is a pioneering platform that leverages blockchain technology to revolutionize the financing and commercialization of early-stage scientific research. By developing a decentralized network of Biotech Decentralized Autonomous Organizations (BioDAOs), BIO enables a global community of scientists, patients, and investors to fund, create, and co-own innovative drugs and therapeutics.
This investment aligns with Binance Labs’ mission to unlock groundbreaking advancements that drive long-term, real-world impact. By supporting projects like BIO Protocol, Binance Labs aims to accelerate the development of innovative solutions that address some of humanity’s most pressing challenges.
BIO Genesis Round 2 is live 🌱
BIO unlocks access to the leading onchain science communities 🧬
Join Genesis now to get $BIO early, prior to the token becoming transferrable.
— BIO Protocol (@bioprotocol) September 30, 2024
With the BIO Protocol, scientists can access alternative funding sources and collaborate with a diverse community of stakeholders to advance their research. Patients can actively participate in the development of treatments for their conditions and receive early access to potential cures. Investors can gain exposure to high-potential scientific ventures and support groundbreaking research.
